» Articles » PMID: 31820851

Prevalence and Incidence of Oral Cancer in Low- and Middle-income Countries: A Scoping Review

Overview
Publisher Wiley
Specialties Nursing
Oncology
Date 2019 Dec 11
PMID 31820851
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Oral cancer is common cancer in many low- and middle-income countries (LMICs) with a low five-year survival rate. It is among the four most common types of cancer in South East Asia region. In South-Central Asia, lip and oral cavity cancer is the second most common cancer according to the specific cancer types.

Methods: This scoping review intended to investigate published studies on the current prevalence and incidence of oral cancer in LMICs. The review was conducted applying the search words "Oral Cancer" and "Mouth neoplasm" as the Medical Subject Heading (MeSH) major topic and "Epidemiology" and ("prevalence" OR "incidence") as the MeSH subheading; the search was supplemented by cross-references. Included studies met the following criteria: original studies, reporting of prevalence or incidence rates, population-based studies, studies in English language and studies involving humans.

Results: The sample sizes ranged from 486 to 101,761 with 213,572 persons included. Buccal mucosa is one of the most common sites of oral cancer, associated with the widespread exposure to chewing tobacco. The incidence is likely to rise in the region where gutkha, pan masala, pan-tobacco and various other forms of chewing tobacco are popular.

Conclusion: This review contributes to useful information on prevalence and incidence estimates of oral cancer in LMICs.

Citing Articles

Epidemiological trends and age-period-cohort effects on lip and oral cavity cancer burden across the BRICS from 1992 to 2021.

Yu Z, Wu Y, Cao Y, Cheng P Front Oncol. 2025; 15:1539417.

PMID: 40034600 PMC: 11873103. DOI: 10.3389/fonc.2025.1539417.


The immunological landscape of CCL26 invasive oral squamous cell carcinoma.

Liu L, Guan S, Xue Y, He Y, Ding L, Fu Y Front Cell Dev Biol. 2025; 13:1502073.

PMID: 39931245 PMC: 11808134. DOI: 10.3389/fcell.2025.1502073.


The global, regional, and national burden of oral cancer, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

Wu J, Chen H, Liu Y, Yang R, An N J Cancer Res Clin Oncol. 2025; 151(2):53.

PMID: 39875744 PMC: 11775039. DOI: 10.1007/s00432-025-06098-w.


Diagnostic performance of artificial intelligence in detecting oral potentially malignant disorders and oral cancer using medical diagnostic imaging: a systematic review and meta-analysis.

Sahoo R, Sahoo K, Dash G, Kumar G, Baliarsingh S, Panda B Front Oral Health. 2024; 5:1494867.

PMID: 39568787 PMC: 11576460. DOI: 10.3389/froh.2024.1494867.


Mangiferin: An effective agent against human malignancies.

Irshad N, Naeem H, Shahbaz M, Imran M, Mujtaba A, Hussain M Food Sci Nutr. 2024; 12(10):7137-7157.

PMID: 39479608 PMC: 11521646. DOI: 10.1002/fsn3.4434.